Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 41

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
,726,933 7,731,171 Ending1,745,573,129 1,736,731,395 1,745,573,129 1,736,731,395 Common stockBeginning$17 $17 $17 $17 Impact of stock-based compensation plans0 0 0 0 Ending$17 $17 $17 $17 Treasury stockBeginning$(2,251)$(2,251)$(2,251)$(2,251)Repurchase of common stock— — — — Ending$(2,251)$(2,251)$(2,251)$(2,251)Additional paid-in capitalBeginning$21,230 $20,803 $21,056 $20,647 Impact of stock-based compensation plans189 160 362 316 Ending$21,419 $20,963 $21,419 $20,963 Retained earningsBeginning$4,144 $1,639 $2,673 $819 Net income (loss)755 468 2,222 1,284 Net (income) loss attributable to noncontrolling interests0 0 4 4 Ending$4,899 $2,107 $4,899 $2,107 Accumulated other comprehensive income (loss), net of tax Beginning$(722)$164 $275 $49 Changes in other comprehensive income (loss)32 (292)(964)(178)Ending$(689)$(128)$(689)$(128)Total stockholders' equity$23,394 $20,708 $23,394 $20,708 Noncontrolling interestsBeginning$235 $238 $233 $248 Net income (loss) attributable to noncontrolling interests(0)(0)(4)(4)Changes in other comprehensive income (loss)1 10 7 4 Ending$236 $248 $236 $248 Total equity$23,630 $20,956 $23,630 $20,956 

Refer to notes to the unaudited consolidated financial statements. Amounts may not add due to rounding.

6

Table of Contents

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Nine Months Ended September